(2R)-2-乙基哌啶 | 22160-08-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: (2R)-2-乙基哌啶
• 英文名称: (-)-R-2-ethylpiperidine
• 英文别名: (R)-2-Ethylpiperidine；(2R)-2-ethylpiperidine
• CAS: 22160-08-3
• 化学式: C₇H₁₅N
• 分子量: 113.203
• InChiKey: QBBKKFZGCDJDQK-SSDOTTSWSA-N

物化性质

• 沸点：
  143.0±0.0 °C(Predicted)
• 密度：
  0.808±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  5-氯-2-甲基异硫氰酸苯酯 、 (2R)-2-乙基哌啶 生成 (R)-N-(5-chloro-2-methylphenyl)-2-ethylpiperidine-1-carbothioamide
  参考文献：
  名称：

  Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents

  摘要：

  A series of 1-alkyl-3-phenylthiourea analogues were prepared and evaluated as HDL- and Apo A-I-elevating and triglyceride-lowering agents. Several derivatives were superior to gemfibrozil (1). The optimal analogue 8d (HDL376) was shown to raise HDL cholesterol in the rat, hamster, dog, and monkey models. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.09.034
• 作为产物：
  描述：

  (7aR,11R,13S)-11-(1H-benzotriazol-1-yl)-7a,8,10,11-tetrahydro-13-phenyl-9H,13H-naphtho[1,2-e]pyrido[2,1-b][1,3]oxazine 在 氢气 、 sodium cyanoborohydride 作用下， 以 甲醇 、 乙醚 、 二氯甲烷 为溶剂， 反应 0.5h， 生成 (2R)-2-乙基哌啶
  参考文献：
  名称：

  Diastereopure Preparation of α-Benzotriazolyl 1-Azacycloalka[2,1-b][1,3]-oxazines and their Application as Versatile Chiral Precursors

  摘要：

  制备了一组非外消旋的贝蒂碱衍生的立体纯α-苯并三氮唑基1-氮杂环烷[2,1-b][1,3]恶嗪。这些化合物被用作制备手性配体和手性取代氮杂环化合物的前体，具有显著的立体选择性优势。

  DOI：

  10.1055/s-2003-43353

文献信息

• Sulfonamides having antiangiogenic and anticancer activity
  申请人：——

  公开号：US20040157836A1

  公开（公告）日：2004-08-12

  Compounds having methionine aminopeptidase-2 inhibitory (MetAP2) are described. Also described are pharmaceutical compositions comprising the compounds, methods of treatment using the compounds, methods of inhibiting angiogenesis, and methods of treating cancer.

  描述了具有蛋氨酸氨基肽酶-2抑制剂（MetAP2）的化合物。还描述了包括这些化合物的药物组合物、使用这些化合物的治疗方法、抑制血管生成的方法以及治疗癌症的方法。
• Pharmaceutically useful pyrazolopyridines
  申请人：Fujisawa Pharmaceutical Company, Ltd.

  公开号：US04925849A1

  公开（公告）日：1990-05-15

  The disclosure deals with a pyrazolopyridine compound of the formula ##STR1## wherein the variables are defined in the specification. The compounds are useful as a diuretic, antihypertensive agent, etc.

  该披露涉及公式为##STR1##的吡唑吡啶化合物，其中变量在规范中定义。这些化合物可用作利尿剂、降压药剂等。
• Kinetic Resolution of Nitrogen Heterocycles with a Reusable Polymer-Supported Reagent
  作者：Imants Kreituss、Yuta Murakami、Michael Binanzer、Jeffrey W. Bode

  DOI：10.1002/anie.201204991

  日期：2012.10.15

  Shake it up baby! Simply shaking a polymer‐supported reagent and the racemic amine at room temperature kinetically resolves a broad range of N‐heterocycles with good selectivity. The polymer‐supported reagents are robust, easy to regenerate, and can be reused dozens of times. Cleavable acyl groups can be used to give access to both amine enantiomers in a single resolution.

  摇摇宝贝！只需在室温下摇晃聚合物支撑的试剂和外消旋胺，就可以动力学分离宽范围的N-杂环，并具有良好的选择性。聚合物支持的试剂坚固耐用，易于再生，可以重复使用数十次。可裂解的酰基可用于以单一分辨率获得两种胺对映体。
• [EN] TRIAZOLE COMPOUNDS USEFUL IN THERAPY<br/>[FR] COMPOSES DE TRIAZOLE UTILISES EN THERAPIE
  申请人：PFIZER LTD

  公开号：WO2004074291A1

  公开（公告）日：2004-09-02

  A compound of formula (I), or a pharmaceutically acceptable derivative thereof, wherein V represents -(CH2)d(O)e-, -CO-, or -CH(C1-6 alkyl)-; W is -0-, -S(O)a , or -N(R1')-R1 represents H, C 1-6 alkyl, (CH2)bCOR2, CO(CH2)bNR2R3, S02R2, (CH2 )cOR2, (CH2)c,NR2R3, or (CH2)bhet1; het1 represents a saturated or unsaturated heterocycle of from 3 to 8 atoms containing one or more heteroatoms selected from O, N, or S, optionally substituted with C 1-6 alkyl; X and Y independently represent H, C 1-6 alkyl, halogen, OH, CF3, OCF3, OR4; Z represents -(CH2)f(O)g , -CO- or -CH(C 1-6 alkyl)-; Ring A represents a 4-7 membered, saturated N-containing heterocycle, optionally substituted with OH, and in which optionally at least one ring N is substituted with O;Ring B represents phenyl or a 4-7 membered unsaturated N-containing heterocycle, optionally substituted with OH, halogen, CN, CONH2, CF3, OCF3, and in which optionally at least one ring N is substituted with O; R2 and R3 independently represent H, C 1-6 alkyl [optionally substituted with OH, halogen,N(C 1.6 alkyl)2, or C 1.6 alkyloxy], C 1.6 alkyloxy, N(C 1-6 alkyl)2, or [C 3-8 cycloalkyl]; or R2 and R3, together with the nitrogen atom to which they are attached independently represent a heterocycle of from 3 to 8 atoms, optionally substituted with C 1-6 alkyl;R4 represents straight or branched C 1-6 alkyl, a and c independently represent 0, 1, or 2; b, e and g independently represent 0 or 1; d and f independently represent 1 or 2;are useful in the treatment of dysmenorrhoea.

  式(I)的化合物，或其药学上可接受的衍生物，其中V代表-(CH2)d(O)e-, -CO-,或-CH(C1-6烷基)-；W为-0-, -S(O)a,或-N(R1')-R1代表H，C1-6烷基，( )bCOR2，CO( )bNR2R3，S02R2，( )cOR2，( )c,NR2R3，或( )bhet1；het1代表一个饱和或不饱和的含有3至8个原子的杂环，其中含有一个或多个从O、N或S中选择的杂原子，可选择地用C1-6烷基取代；X和Y独立地代表H，C1-6烷基，卤素，OH，CF3，O ，或OR4；Z代表-( )f(O)g，-CO-或-CH(C1-6烷基)-；环A代表一个4-7成员的饱和N-含杂环，可选择地用OH取代，并且其中可选择地至少一个环N用O取代；环B代表苯或一个4-7成员的不饱和N-含杂环，可选择地用OH，卤素，CN，CONH2， ，O 取代，并且其中可选择地至少一个环N用O取代；R2和R3独立地代表H，C1-6烷基[可选择地用OH，卤素，N(C1-6烷基)2，或C1-6烷氧基取代]，C1-6烷氧基，N(C1-6烷基)2，或[C3-8环烷基]；或R2和R3，连同它们附着的氮原子，独立地代表一个含有3至8个原子的杂环，可选择地用C1-6烷基取代；R4代表直链或支链C1-6烷基，a和c独立地代表0，1，或2；b，e和g独立地代表0或1；d和f独立地代表1或2；在痛经的治疗中是有用的。
• Pyrazolopyridine compound and processes for preparation thereof
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04994453A1

  公开（公告）日：1991-02-19

  The disclosure deals with pyrazolopyridine compounds of the formula ##STR1## wherein the variables are defined in the specification. The compounds are useful in the treatment of bronchial asthma, immunosuppression, diabetes, etc.

  该披露涉及公式为##STR1##的吡唑吡啶化合物，其中变量在规范中定义。这些化合物在治疗支气管哮喘、免疫抑制、糖尿病等方面是有用的。